|
|
 |
Caroline M. Apovian, MD |
|
|
 |
Edmund Pezalla, MD, PhD, MPH |
The Heavy Burden of Obesity Management in Health Care Web Activity
|
||||||||
| EXPERT FACULTY | ||||||||
|
||||||||
|
||||||||
Target Audience
Statement of Need/Program Overview
Obesity is a health care epidemic and one of the major drivers of health care costs in the United States. Excess adiposity affects most organ systems and obesity is linked to a wide range of comorbidities, including hypertension, type 2 diabetes, heart disease, and certain cancers. When aggregated across payers, obesity accounts for approximately 9.1% of total medical expenditures.
The first track of “The Heavy Burden of Obesity Management in Health Care” series, will look at the direct and indirect costs for obesity, barriers to obesity disease management, and strategies managed care professionals can use to combat barriers and improve patient outcomes. Track 2 examines the currently available and emerging obesity treatment options as well as two case studies.
Educational Objectives
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
Track 1
Track 2
ACCREDITATION
Joint Accreditation Statement
|
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, Academy of Managed Care Pharmacy, and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Credit Designation
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Track 1: 0.75 CME credit
Track 2: 0.75 CME credit
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Track 1: 0.75 CNE credit
Track 2: 0.75 CNE credit
Continuing Pharmacy Education
|
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Track 1:
Track 2:
Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
| Name of Faculty or Presenter | Reported Financial Relationship |
| Caroline M. Apovian, MD | Advisory Boards: Nutrisystem, Xeno Biosciences; Consultant: Gelesis, GI Dynamics, Novo Nordisk, Rhythm, Sanofi Aventis, Takeda Pharmaceutical, Zafgen; Grants/Research: Aspire Bariatrics, Gelesis, GI Dynamics, Novo Nordisk, Takeda Pharmaceutical |
| Edmund Pezalla, MD, PhD, MPH | Dr. Pezalla has nothing to disclose |
The PIM, AMCP, and Impact Education, LLC planners and managers have nothing to disclose.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period of accreditation participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 75% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, a certificate will be made available immediately to download and print.
MEDIA
Internet
FEE INFORMATION
There is no fee for this educational activity.